HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maintenance of human amnion epithelial cell phenotype in pulmonary surfactant.

AbstractINTRODUCTION:
Preterm newborns often require mechanical respiratory support that can result in ventilation-induced lung injury (VILI), despite exogenous surfactant treatment. Human amnion epithelial cells (hAECs) reduce lung inflammation and resultant abnormal lung development in preterm animals; co-administration with surfactant is a potential therapeutic strategy. We aimed to determine whether hAECs remain viable and maintain function after combination with surfactant.
METHODS:
hAECs were incubated in surfactant (Curosurf) or phosphate-buffered saline (PBS) for 30 minutes at 37°C. Cell viability, phenotype (by flow cytometry), inhibition of T-cell proliferative responses and differentiation into lung epithelium-like cells (assessed with immunohistochemical staining of surfactant protein (SP)-A) were investigated.
RESULTS:
Cell viability and apoptosis of hAECs were not altered by surfactant, and hAEC phenotype was not altered. hAECs maintained expression of epithelial cell adhesion molecule (EpCAM) and human leukocyte antigen (HLA)-ABC after surfactant exposure. Expression of HLA-DR, CD80 and CD86 was not increased. Immunosuppression of T cells by hAECs was not altered by surfactant. hAEC differentiation into lung epithelium-like cells was equivalent after exposure to PBS or surfactant, and SP-A expression was equivalent.
CONCLUSION:
Surfactant exposure does not alter viability or function of hAECs. Thus a combination therapy of hAECs and surfactant may be an efficacious therapy to ameliorate or prevent preterm lung disease.
AuthorsCourtney A McDonald, Jacqueline M Melville, Graeme R Polglase, Graham Jenkin, Timothy J M Moss
JournalStem cell research & therapy (Stem Cell Res Ther) Vol. 5 Issue 5 Pg. 107 (Sep 04 2014) ISSN: 1757-6512 [Electronic] England
PMID25189170 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biological Products
  • Phospholipids
  • Pulmonary Surfactants
  • poractant alfa
Topics
  • Amnion (cytology, drug effects, metabolism)
  • Animals
  • Apoptosis (drug effects)
  • Biological Products (pharmacology)
  • Cell Culture Techniques (methods)
  • Cell Survival (drug effects)
  • Epithelial Cells (cytology, drug effects, metabolism)
  • Female
  • Flow Cytometry
  • Humans
  • Infant, Newborn
  • Mice
  • Mice, Inbred C57BL
  • Phenotype
  • Phospholipids (pharmacology)
  • Pregnancy
  • Pulmonary Surfactants (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: